alnylam pipeline: fitusiran and inclisiran
Published 5 years ago • 463 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
3:14
alnylam pharmaceuticals cmo, dr. akshay vaishnaw, explains rnai
-
0:55
what is an rnai therapeutic?
-
2:32
what is rnai and how do rnai-based medicines work?
-
1:07
alnylam's pending approval of patisiran
-
3:31
fitusiran and hemophilia: early data very promising
-
40:09
inflammasome activation in autoinflammatory diseases: from signaling pathways to functional diagno..
-
2:56
rnai therapeutics - how this new class of medicines works
-
6:59
improving population health | introducing inclisiran into the lipid management pathway
-
2:29
phase i first-in-human study of alnuctamab in patients with r/r multiple myeloma
-
11:26
alnylam’s phase 3 clinical trials with givosiran
-
0:54
alnylam’s stock takes a hit amid trial results #trading #investing #stockmarket
-
1:15
the safety and efficacy of peritransplantation ruxolitinib in patients with mf
-
2:22
givosiran to treat acute hepatic porphyria
-
1:19
next steps for research into the nlrp3 inflammasome in dementia
-
3:35
endothelin-1 in hemodialysis patients
-
0:30
lipoprotein(a) clinical trials: sln 360
-
1:38
dr. ramalingam on avelumab plus lorlatinib in nsclc
-
14:58
what is an alanine aminotransferase (alt) blood test?
-
8:10
sveinbjornsson et al; variants in nkx2-5 and flnc cause dcm
-
2:31
aall0631: lestaurtinib for infant all
-
1:24
diagnosis: eln recommendations
-
29:21
2017 la net conf-18 summary: mailman